You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-TNFRSF1A (TNFRSF1A) Antibodies

Full name:
anti-Tumor Necrosis Factor Receptor Superfamily, Member 1A Antibodies (TNFRSF1A)
On are 446 Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) Antibodies from 36 different suppliers available. Additionally we are shipping TNFRSF1A Proteins (65) and TNFRSF1A Kits (60) and many more products for this protein. A total of 596 TNFRSF1A products are currently listed.
CD120a, FPF, MS5, p55, p55-R, p60, TBP1, TNF-alphaR1, TNF-R, TNF-R-I, TNF-R1, TNF-R55, TNFalpha-R1, TNFAR, Tnfr-2, Tnfr1, TNFR1-d2, TNFR55, TNFR60, TNFR I, TNFRI, TNFRp55, TNFRSF1A, wu:fj65b10, xtnfr1, zgc:85914
list all antibodies Gene Name GeneID UniProt
TNFRSF1A 7132 P19438
TNFRSF1A 21937 P25118
TNFRSF1A 25625 P22934

Show all species

Show all synonyms

All available anti-TNFRSF1A Antibodies

Go to our pre-filtered search.

Top referenced anti-TNFRSF1A Antibodies

  1. Human Monoclonal TNFRSF1A Primary Antibody for FACS, Neut - ABIN4900865 : Dong, Kleinberg, Silins, Flørenes, Tropé, Risberg, Nesland, Davidson: Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma. in Cancer 2007 (PubMed)
    Show all 12 references for ABIN4900865

  2. Human Monoclonal TNFRSF1A Primary Antibody for FACS - ABIN4898906 : Rebelo, Bainbridge, Amel-Kashipaz, Radford, Powell, Todd, Tighe: Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. in Arthritis and rheumatism 2006 (PubMed)
    Show all 12 references for ABIN4898906

  3. Human Monoclonal TNFRSF1A Primary Antibody for FACS, IHC (fro) - ABIN111938 : Brockhaus, Schoenfeld, Schlaeger, Hunziker, Lesslauer, Loetscher: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. in Proceedings of the National Academy of Sciences of the United States of America 1990 (PubMed)
    Show all 7 references for ABIN111938

  4. Human Monoclonal TNFRSF1A Primary Antibody for FACS, IHC (fro) - ABIN111937 : Ryffel, Brockhaus, Dürmüller, Gudat: Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha. in The American journal of pathology 1991 (PubMed)
    Show all 7 references for ABIN111937

  5. Human Polyclonal TNFRSF1A Primary Antibody for EIA, IHC (p) - ABIN358242 : Kuo, Lympany, Menezo, Lagan, John, Yeo, Liyanage, du Bois, Welsh, Lightman: TNF-857T, a genetic risk marker for acute anterior uveitis. in Investigative ophthalmology & visual science 2005 (PubMed)
    Show all 5 references for ABIN358242

  6. Human Polyclonal TNFRSF1A Primary Antibody for EIA, FACS - ABIN951180 : Wolańska, Taudul, Bańkowska-Guszczyn, Kinalski: [Tumor necrosis factor in uterine leiomyomas at various stages of tumor growth]. in Ginekologia polska 2010 (PubMed)
    Show all 3 references for ABIN951180

  7. Human Monoclonal TNFRSF1A Primary Antibody for FACS - ABIN4898905 : Laarman, Mijnheer, Mootz, van Rooijen, Ruyken, Malone, Heezius, Ward, Milligan, van Strijp, de Haas, Horswill, van Kessel, Rooijakkers: Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. in The EMBO journal 2012 (PubMed)
    Show all 2 references for ABIN4898905

  8. Guinea Pig Polyclonal TNFRSF1A Primary Antibody for IF, WB - ABIN2792105 : Gattorno, Sormani, DOsualdo, Pelagatti, Caroli, Federici, Cecconi, Solari, Meini, Zulian, Obici, Breda, Martino, Tommasini, Bossi, Govers, Touitou, Woo, Frenkel, Koné-Paut, Baldi, Ceccherini, Martini: A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. in Arthritis and rheumatism 2008 (PubMed)

  9. Human Monoclonal TNFRSF1A Primary Antibody for FACS - ABIN4898903 : Hijdra, Vorselaars, Grutters, Claessen, Rijkers: Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes. in Journal of inflammation (London, England) 2013 (PubMed)

  10. Human Polyclonal TNFRSF1A Primary Antibody for EIA, FACS - ABIN951179 : Giroux, Elfassihi, Clément, Bussières, Bureau, Cole, Rousseau: High-density polymorphisms analysis of 23 candidate genes for association with bone mineral density. in Bone 2010 (PubMed)

More Antibodies against TNFRSF1A Interaction Partners

Human Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) interaction partners

  1. Voxel-based morphometry was used to analyse the associations between TNFRSF1A (rs4149576 and rs4149577) and grey matter structure. Highly significant genotypic associations with striatal volume but not the hippocampus were seen. Specifically, for rs4149576, G homozygotes were associated with reduced caudate nucleus volumes relative to A homozygotes and heterozygotes. Reduced caudate volumes were observed in C homozygotes

  2. Circulating TNFR1 and 2 were shown to be associated with cardiovascular disease, independent of age, sex, inflammatory markers, and other cardiovascular disease risk factors, in the chronic kidney disease patients

  3. Infection with C. trachomatis disturbs TNFR1 signalling specifically at the level of receptor internalization.

  4. Data suggest that TRAF2 (TNF receptor-associated factor 2 (show TRAF2 Antibodies)) negatively regulates (1) TNFR1- (tumor necrosis factor binding protein 1)-induced apoptosis, (2) TNFR2 (show TNFRSF1B Antibodies)- (tumor necrosis factor (show TNF Antibodies) receptor type 2)-induced non-canonical NFkappaB (show NFKB1 Antibodies) signaling, and (3) TNF- (tumor necrosis factor (show TNF Antibodies))-induced necroptosis. [REVIEW]

  5. Our analysis showed that the TNFR1 rs2234649 polymorphism does not increase ankylosing spondylitis risk. In conclusion, the TNFR1 gene polymorphism tested does not appear to be useful for assessing predisposition to ankylosing spondylitis.

  6. The data demonstrate a novel and unexpected function of BIG1 (show CNTN3 Antibodies) that regulates TNFR1 signaling by targeting TRAF2 (show TRAF2 Antibodies).

  7. Data indicate that plasma concentrations of TNFR1 and TNFR2 (show TNFRSF1B Antibodies) are elevated in pediatric lupus nephritis.

  8. TNFR1 is the major pro-inflammatory mediator of TNF-alpha in fibroblast-like synoviocytes (FLS), whereas TNFR2, may act as an immunosuppressor in FLS for the prevention of overwhelming inflammatory reactions.

  9. These results strongly indicate that anti-inflammatory effects in TNF-alpha (show TNF Antibodies)-stimulated endothelial cells by acetylation are tightly linked to secreted APE1/Ref-1 (show APEX1 Antibodies), which inhibits TNF-alpha (show TNF Antibodies) binding to TNFR1 by reductive conformational change, with suggestion as an endogenous inhibitor of vascular inflammation.

  10. Results suggest that miR (show MLXIP Antibodies)-29a is an important regulator of tumor necrosis factor receptor 1 expression in breast cancer and functions as a tumor suppressor by targeting tumor necrosis factor receptor 1 to influence the growth of MCF-7 cell.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) interaction partners

  1. Results suggest that elevated TNF (show TNF Antibodies) in the heart, via TNFR1 and TNFR2 (show TNFRSF1B Antibodies), restrains cardiomyocyte differentiation of resident cardiac stem cells and may enhance adrenergic activation, both effects that would reduce the effectiveness of endogenous cardiac repair and the response to exogenous stem cell therapy, while promoting adverse cardiac remodeling.

  2. Suggest an atheroprotective role of ADAM17 (show ADAM17 Antibodies), which might be mediated by cleaving membrane-bound TNFalpha (show TNF Antibodies) and TNFR2 (show TNFRSF1B Antibodies), thereby preventing overactivation of endogenous TNFR2 (show TNFRSF1B Antibodies) signaling in cells of the vasculature.

  3. Using in vivo, time-lapse imaging we show that as centrally-projecting pioneer axons from dorsal root ganglia (DRG) enter the spinal cord, they initiate expression of the cytokine TNFalpha (show TNF Antibodies). This induction coincides with ensheathment of these axons by associated glia via a TNF (show TNF Antibodies) receptor 2 (TNFR2 (show TNFRSF1B Antibodies))-mediated process.

  4. this study shows that Tnfr1 knock-out display reduced chemotaxis of myeloid-derived suppressor cells to tumor, and mice reject transplanted tumor

  5. tumor necrosis factor-alpha (show TNF Antibodies), through its receptor tumor necrosis factor receptor -1, promoted cell proliferation and cell survival in prostate by activation of the AKT (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) and NFKB pathway, which stimulated prostate carcinogenesis

  6. Report chronic inflammatory multiorgan hepatobiliary pancreatitis, along with fibrosis and calculi formation induced by oral dibutyltin administration in TNFR1/R2 deficient mice.

  7. Data, including data from studies in knockout mice, suggest that TNF (tumor necrosis factor (show TNF Antibodies)), TNFR1 (TNF (show TNF Antibodies) receptor 1), and IL18 (interleukin 18 (show IL18 Antibodies)) are involved in liver lipid metabolism. IL18 (show IL18 Antibodies) or TNFR1 knockout mice on chow show higher liver triglyceride deposition than wild-type mice fed chow; in IL18 (show IL18 Antibodies) or TNFR1 knockout mice, high-refined-carbohydrate diet does not lead to fatty liver disease as it does in wild-type mice.

  8. Knockdown of TNFR1 not only inhibited the JNK (show MAPK8 Antibodies) pathway but also reduced Toll-like receptor 2 (show TLR2 Antibodies) protein and RANKL (show TNFSF11 Antibodies) levels in S. aureus-infected cells.

  9. we have demonstrated that PGRN (show GRN Antibodies)-mediated inhibition of chemokine (show CCL1 Antibodies) expression largely depends on TNFR1.

  10. The results of comparative analysis of interaction between the protein cytotoxic complex Tag 7 (show PGLYRP1 Antibodies)-Hsp70 (show HSP70 Antibodies) and the Tag 7 (show PGLYRP1 Antibodies) component of this complex with TNFR1 receptor in solution and in tumor cells are presented.

Pig (Porcine) Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) interaction partners

  1. Retinal ischemia results in increased expression of TNF-alpha (show TNF Antibodies) and its receptors (TNF-R1 and TNF-R2 (show TNFRSF1B Antibodies)).

Cow (Bovine) Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) interaction partners

  1. These results suggest that TNF-alpha (show TNF Antibodies) sources include immune cells, as well as large and small luteal cells, and that TNF-RI and TNF-RII (show TNFRSF1B Antibodies) are present in the luteal cells of the bovine corpus luteum.

  2. The expression and cellular localization of tumor necrosis factor-alpha (TNF (show TNF Antibodies)) and its receptors (TNFRI and TNFRII (show TNFRSF1B Antibodies)) mRNAs and proteins, were determined.

  3. The upregulation of TNFRI mRNA expression by IFNG (show IFNG Antibodies) suggests that TNF (show TNF Antibodies) and IFNG (show IFNG Antibodies) synergistically affect the death of luteal endothelial cells resulting in acute luteolysis

  4. TNF (show TNF Antibodies) binding induces release of AIP1 (DAB2IP (show DAB2IP Antibodies)) from TNFR1, resulting in cytoplasmic translocation and concomitant formation of an intracellular signaling complex comprised of TRADD (show TRADD Antibodies), RIP1 (show RALBP1 Antibodies), TRAF2 (show TRAF2 Antibodies), and AIPl.

Zebrafish Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) interaction partners

  1. Targeted gene knockdown of TNFRSF1B (show TNFRSF1B Antibodies) in zebrafish embryos results in the induction of a caspase-8 (show CASP8 Antibodies), caspase-2 (show CASP2 Antibodies) and P53 (show TP53 Antibodies)-dependent apoptotic program in endothelial cells that bypasses caspase-3 (show CASP3 Antibodies).

TNFRSF1A Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein is one of the major receptors for the tumor necrosis factor-alpha. This receptor can activate NF-kappaB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the signal transduction mediated by the receptor. Germline mutations of the extracellular domains of this receptor were found to be associated with the autosomal dominant periodic fever syndrome. The impaired receptor clearance is thought to be a mechanism of the disease.

Alternative names and synonyms associated with TNFRSF1A

  • tumor necrosis factor receptor superfamily, member 1A (tnfrsf1a) antibody
  • tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A) antibody
  • tumor necrosis factor receptor superfamily, member 1a (Tnfrsf1a) antibody
  • tumor necrosis factor receptor superfamily, member 1A (Tnfrsf1a) antibody
  • tumor necrosis factor receptor superfamily, member 1a (tnfrsf1a) antibody
  • CD120a antibody
  • FPF antibody
  • MS5 antibody
  • p55 antibody
  • p55-R antibody
  • p60 antibody
  • TBP1 antibody
  • TNF-alphaR1 antibody
  • TNF-R antibody
  • TNF-R-I antibody
  • TNF-R1 antibody
  • TNF-R55 antibody
  • TNFalpha-R1 antibody
  • TNFAR antibody
  • Tnfr-2 antibody
  • Tnfr1 antibody
  • TNFR1-d2 antibody
  • TNFR55 antibody
  • TNFR60 antibody
  • TNFR I antibody
  • TNFRI antibody
  • TNFRp55 antibody
  • TNFRSF1A antibody
  • wu:fj65b10 antibody
  • xtnfr1 antibody
  • zgc:85914 antibody

Protein level used designations for TNFRSF1A

tumor necrosis factor receptor 1 , tumor necrosis factor receptor p60 , tumor necrosis factor receptor superfamily member 1A , tumor necrosis factor type I , tumor necrosis factor receptor superfamily, member 1A , tumor necrosis factor receptor superfamily member 1A-like , TNF-R1 , TNF-RI , TNFR-I , tumor necrosis factor binding protein 1 , tumor necrosis factor receptor 1A isoform beta , tumor necrosis factor receptor type 1 , tumor necrosis factor-alpha receptor , TNF receptor alpha chain , TNF-alpha-R1 , p60 , tumor necrosis factor receptor type I , p55 , p55 TNF receptor , TNF Receptor 1 (TR1) , TNFR1

100137626 Xenopus laevis
100144930 Xenopus (Silurana) tropicalis
403634 Canis lupus familiaris
466934 Pan troglodytes
493957 Felis catus
722033 Macaca mulatta
100059548 Equus caballus
100135698 Ovis aries
100397418 Callithrix jacchus
7132 Homo sapiens
21937 Mus musculus
25625 Rattus norvegicus
397020 Sus scrofa
282527 Bos taurus
418325 Gallus gallus
100713890 Cavia porcellus
406471 Danio rerio
Selected quality suppliers for anti-TNFRSF1A (TNFRSF1A) Antibodies
Did you look for something else?